Digital Health App Tracks Pain Progress With Neurostimulation Therapy
Patients will be able to share information collected in the app with health care providers to provide a comprehensive assessment of the SCS or DRG therapy.
Article Type: News
Lower Risk of CKD Stage Progression Found With Apixaban
Kidney injury may be less among patients with chronic kidney disease and atrial fibrillation taking apixaban versus warfarin for anticoagulation, new research suggests.
Pfizer-BioNTech COVID-19 Vaccine Elicits Response Against Key Mutation
The study was conducted by Pfizer and the University of Texas Medical Branch.
FDA Clears Rapid Blood Test for Mild Traumatic Brain Injury
The test measures glial fibrillary acidic protein and ubiquitin carboxyl-terminal hydrolase L1, biomarkers present in blood plasma at elevated concentrations after a brain injury.
FDA: SARS-CoV-2 Mutations May Impact Molecular Tests
The FDA is alerting clinical laboratory staff and health care providers regarding the risk of false negative results with any SARS-CoV-2 test if a mutation occurs in the part of the virus’ genome assessed by that test.
Statins May Benefit Patients Receiving ADT for Relapsed Prostate Cancer
In a study, statin use was associated with a 36% decreased risk for death among men initiating androgen deprivation therapy for recurrent prostate cancer following primary or salvage radiation therapy.
False Results Possible With Curative SARS-CoV-2 Test, Says FDA
The test should be utilized in accordance with its Emergency Use Authorization and as described in the authorized labeling to reduce the risk of false negative results.
Sutab Tablets Now Available for Colonoscopy Prep
The product is administered as a split-dose regimen consisting of 2 doses.
Experts Weigh In on the Best Diets for 2021
An expert panel assessed 39 diets to come up with the final results, examining the evidence behind each diet’s claims.
Tepezza Supply Shortage Expected Soon
As both the vaccine and Tepezza are being manufactured at Catalent, the government has prioritized the manufacturing of the vaccine thereby resulting in cancellation of previously contracted Tepezza orders.
